There were 521 press releases posted in the last 24 hours and 442,752 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image